At JPM, Nvidia unveiled partnerships with Eli Lilly, Thermo Fisher and others that show how the chipmaker is pushing its AI beyond models and into the core infrastructure of drug discovery and research labs. The moves highlight Nvidia’s ambitions to become a foundational technology provider for the pharma industry.
The post Nvidia Deepens Push Into Drug Discovery Via New Partnerships with Lilly, Thermo Fisher & More appeared first on MedCity News.
